Liver regeneration can occur by proliferation of two different cell types, but generally only one at a time is fully turned on. A factor that may specifically activate one of these cell types now comes to light.
This is a preview of subscription content, log in via an institution to check access.
Katie Ris
References
Jakubowski, A. et al. J. Clin. Invest. 115, 2330–2340 (2005).
Fausto, N. Hepatology 39, 1477–1487 (2004).
Knight, B. and Yeoh, G.C. Cell Tissue Res. 319, 61–70 (2005).
Feng, S.L. et al. Am. J. Pathol. 156, 1253–1261 (2000).
Akhurst, B. et al. Hepatology 41, 327–335 (2005).
Anders, R.A. et al. J. Immunol. 175, 1295–1300 (2005).
Brooling, J.T. et al. Hepatology 41, 906–915 (2005).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fausto, N. Tweaking liver progenitor cells. Nat Med 11, 1053–1054 (2005). https://doi.org/10.1038/nm1005-1053
Issue Date:
DOI: https://doi.org/10.1038/nm1005-1053
- Springer Nature America, Inc.
This article is cited by
-
Reduced circulating levels of sTWEAK are associated with NAFLD and may affect hepatocyte triglyceride accumulation
International Journal of Obesity (2016)
-
Inflammation and liver tumorigenesis
Frontiers of Medicine (2013)
-
TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration
The EMBO Journal (2006)
-
Current status and perspective of antiangiogenic therapy for cancer: hepatocellular carcinoma
International Journal of Clinical Oncology (2006)